Immix Biopharma Inc
NASDAQ:IMMX
Balance Sheet
Balance Sheet Decomposition
Immix Biopharma Inc
Immix Biopharma Inc
Balance Sheet
Immix Biopharma Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
1
|
0
|
18
|
13
|
18
|
18
|
|
| Cash Equivalents |
1
|
0
|
18
|
13
|
18
|
18
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
2
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
1
|
1
|
18
|
15
|
20
|
20
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
3
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
3
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
-43%
|
18
+3 269%
|
15
-18%
|
20
+34%
|
23
+15%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
5
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
2
|
3
|
|
| Short-Term Debt |
4
|
4
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
5
|
5
|
0
|
1
|
4
|
9
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Liabilities |
5
N/A
|
5
+15%
|
0
-96%
|
2
+775%
|
4
+101%
|
10
+175%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
5
|
30
|
38
|
53
|
75
|
|
| Additional Paid In Capital |
1
|
1
|
48
|
51
|
70
|
88
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
5
-30%
|
18
N/A
|
13
-27%
|
16
+25%
|
13
-19%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
-43%
|
18
+3 269%
|
15
-18%
|
20
+34%
|
23
+15%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
7
|
7
|
13
|
14
|
20
|
28
|
|